Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelial Interleukin-1 Receptor-Like-1 Activation Is Contingent on Interleukin-33 Isoforms and Asthma-Related Receptor Variation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2024
Same author

Neutrophilic Asthma Is Associated With Smoking, High Numbers of IRF5+, and Low Numbers of IL10+ Macrophages.

Frontiers in allergy·2022
Same author

Paracrine Regulation of Alveolar Epithelial Damage and Repair Responses by Human Lung-Resident Mesenchymal Stromal Cells.

Cells·2021
Same author

Identification of asthma-associated microRNAs in bronchial biopsies.

The European respiratory journal·2021
Same author

Abnormalities in reparative function of lung-derived mesenchymal stromal cells in emphysema.

American journal of physiology. Lung cellular and molecular physiology·2021
Same author

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

Scientific reports·2020

Related Experiment Video

Updated: May 10, 2026

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium
07:40

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium

Published on: February 21, 2025

Caveolin-1 controls airway epithelial barrier function. Implications for asthma.

Tillie-Louise Hackett1, Harold G de Bruin, Furquan Shaheen

  • 11 University of British Columbia James Hogg Research Centre, Heart and Lung Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada; and.

American Journal of Respiratory Cell and Molecular Biology
|June 8, 2013
PubMed
Summary

Reduced caveolin-1 in asthma airways impairs epithelial barrier function and promotes allergic responses. Restoring caveolin-1 improves barrier integrity and reduces pro-allergic cytokine release, highlighting its therapeutic potential.

More Related Videos

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
14:48

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies

Published on: December 26, 2012

Related Experiment Videos

Last Updated: May 10, 2026

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium
07:40

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium

Published on: February 21, 2025

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
14:48

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies

Published on: December 26, 2012

Area of Science:

  • Cell Biology
  • Immunology
  • Respiratory Medicine

Background:

  • Airway epithelial fragility in asthma is not fully understood.
  • Caveolin-1 stabilizes adherens junctions and may be involved in asthma pathogenesis.

Purpose of the Study:

  • To investigate the role of caveolin-1 in asthma-related epithelial barrier dysfunction.
  • To determine if reduced caveolin-1 contributes to increased pro-allergic activity in asthma.

Main Methods:

  • Studied caveolin-1, E-cadherin, and β-catenin expression in asthma patient airway sections and cultured cells.
  • Manipulated caveolin-1 levels in human bronchial epithelial cell lines (16HBE, BEAS-2B) to assess effects on barrier function and TSLP production.

Main Results:

  • Lower membrane caveolin-1 expression in asthma airways, maintained in vitro.
  • Reduced caveolin-1 correlated with loss of E-cadherin/β-catenin, impaired barrier function, and increased thymic stromal lymphopoietin (TSLP).
  • Caveolin-1 down-regulation caused E-cadherin delocalization and barrier dysfunction; overexpression improved barrier function and reduced TSLP.

Conclusions:

  • Caveolin-1 is crucial for epithelial cell-cell adhesion and maintaining airway barrier integrity in asthma.
  • Loss of caveolin-1 contributes to airway dysfunction and promotes Th2-mediated allergic inflammation in asthma.
  • Targeting caveolin-1 may offer a therapeutic strategy for improving asthma control.